<DOC>
	<DOCNO>NCT02172443</DOCNO>
	<brief_summary>The objective study compare bronchodilator efficacy safety tiotropium inhalation capsule ( 18 mcg daily ) Atrovent MDI ( 2 puff 20 mcg q.i.d . ) patient chronic obstructive pulmonary disease ( COPD )</brief_summary>
	<brief_title>Comparison Tiotropium Inhalation Capsules Atrovent Metered Dose Inhaler ( MDI ) Efficacy Safety Study Adults With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>COPD patient force expiratory volume one second ( FEV1 ) &lt; = 65 % predict normal FEV1 &lt; = 70 % forced vital capacity ( FVC ) Male female patient 40 year age old . Patient must smoke history 10 packyears . A packyear defined equivalent smoking pack cigarette per day year . Patient must able perform pulmonary function test require protocol . Patient must able inhale medication handihaler device good technique inhale aerosol administer MDI . All patient must sign informed consent prior participation trail , prior prestudy washout usual pulmonary medication . Patient significant disease COPD exclude . A significant disease define disease opinion investigator may either put patient risk participation study disease may influence result study patient 's ability participate study . Patients clinically significant abnormal baseline hematology , blood chemistry urinalysis , abnormality defines disease list exclusion criterion exclude . All patient serum glutamicoxaloacetic transaminase ( SGOT ) serum glutamicpyruvic transaminase ( SGPT ) twice upper normal limit , bilirubin 150 % creatinine 125 % upper normal limit exclude regardless clinical condition . Repeat laboratory evaluation conduct subject . Patients recent history ( i.e . one year less ) myocardial infarction . Patients recent history ( i.e . one year less ) heart failure patient cardiac arrhythmia require drug therapy . Patients regular use daytime oxygen therapy . Patients know active tuberculosis . Patients history cancer within last five year . Patients treat basal cell carcinoma allow . Patients history lifethreatening pulmonary , history cystic fibrosis bronchiectasis . Patients undergone pulmonary resection thoracotomy reason . Patients upper respiratory tract infection past 2 week prior screen visit ( = Visit 1 ) baseline period 2weeks ( runin period ) . Patients know hypersensitivity anticholinergic drug , lactose component inhalation capsule delivery system . Patients know symptomatic prostatic hypertrophy bladder neck obstruction . Patients know narrowangle glaucoma . Patients treat cromolyn sodium nedocromil sodium . Patients treat antihistamine . Patients use oral corticosteroid medication unstable dosage ( i.e . le 6 week stable dose ) dose excess equivalent 10 mg prednisone per day 20 mg every day . Pregnant nursing woman woman childbearing potential use medically approve mean contraception ( e.g . oral contraceptive , intrauterine device , diaphragm ) . Patients history asthma , allergic rhinitis atopy blood total eosinophil count &gt; = 400 per microliter ( male ) &gt; = 320 per microliter ( female ) . A repeat eosinophil count conduct patient . Patients history and/or active alcohol drug abuse . Patients take investigational drug month six halflives ( whichever great ) prior screen visit ( = Visit 1 ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>